XML 49 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2018
Equity [Abstract]  
Schedule of Number of Shares of Common Stock Reserved for Future Issuance

The Company has reserved for future issuance the following number of shares of common stock:

 

 

 

March 31, 2018

 

 

December 31, 2017

 

Unvested restricted stock

 

 

914,648

 

 

 

1,164,040

 

Common stock options

 

 

478,132

 

 

 

666,717

 

Shares available for issuance under the 2013 Stock Option and

   Incentive Plan

 

 

4,781,183

 

 

 

3,273,334

 

Shares available for issuance under the 2013 Employee Stock

   Purchase Plan

 

 

788,503

 

 

 

788,503

 

 

 

 

6,962,466

 

 

 

5,892,594

 

 

Summary of Roll Forward of Restricted Stock Activity Pursuant to the 2010 and 2013 Stock Plan

The following table shows a roll forward of restricted stock activity pursuant to the 2010 Stock Plan and the 2013 Stock Plan:

 

 

 

Number of

Shares

 

Unvested at December 31, 2017

 

 

1,164,040

 

Granted

 

 

43,905

 

Vested

 

 

(207,016

)

Forfeited

 

 

(86,281

)

Unvested at March 31, 2018

 

 

914,648

 

 

Summary of Stock Option Activity Under the 2010 Stock Plan and the 2013 Stock Plan

A summary of stock option activity under the 2010 Stock Plan and the 2013 Stock Plan for the three months ended March 31, 2018 is as follows:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise

Price

 

 

Weighted-

Average

Remaining

Contractual

Term

(In Years)

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(in thousands)

 

Outstanding as of December 31, 2017

 

 

666,717

 

 

$

19.53

 

 

 

5.6

 

 

$

32,450

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(184,783

)

 

 

18.56

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(3,802

)

 

 

25.40

 

 

 

 

 

 

 

 

 

Outstanding as of March 31, 2018

 

 

478,132

 

 

$

19.86

 

 

 

5.3

 

 

$

28,159

 

Exercisable as of March 31, 2018

 

 

440,089

 

 

$

18.74

 

 

 

5.1

 

 

$

26,409

 

 

Recorded Stock-Based Compensation Expense in the Consolidated Statements of Operations and Comprehensive Loss

The Company recorded stock-based compensation expense in the statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2018

 

 

2017

 

Cost of revenue

 

$

238

 

 

$

1,095

 

Selling and marketing

 

 

912

 

 

 

1,220

 

General and administrative

 

 

1,281

 

 

 

2,778

 

Research and development

 

 

777

 

 

 

1,306

 

Total

 

$

3,208

 

 

$

6,399